Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells

Monica Limonta, Andrea Biondi, Giovanni Giudici, Giorgina Specchia, Carlo Catapano, Giuseppe Masera, Tiziano Barbui, Maurizio D'Incalci

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

4-Demethoxydaunorubicin (4-DMDR) and its major metabolite 4-demethoxy-13-hydroxydaunorubicin (4-DMDRol) were investigated for their cytotoxicity and mode of action against human leukemic cells. The drug and its metabolite appeared to be equally potent as both inhibitors of cell proliferation and inducers of DNA double-strand breaks in the OCI AML-3 cell line and cells derived directly from patients with acute myeloid leukemia (AML). This suggests that 4-DMDRol plays an important role in the antileukemic activity of 4-DMDR.

Original languageEnglish
Pages (from-to)340-342
Number of pages3
JournalCancer Chemotherapy and Pharmacology
Volume26
Issue number5
DOIs
Publication statusPublished - Sep 1990

Fingerprint

Idarubicin
Myeloid Cells
Cytotoxicity
Metabolites
Acute Myeloid Leukemia
DNA Damage
Double-Stranded DNA Breaks
DNA
Cell proliferation
Cells
Cell Proliferation
Cell Line
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Cite this

Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells. / Limonta, Monica; Biondi, Andrea; Giudici, Giovanni; Specchia, Giorgina; Catapano, Carlo; Masera, Giuseppe; Barbui, Tiziano; D'Incalci, Maurizio.

In: Cancer Chemotherapy and Pharmacology, Vol. 26, No. 5, 09.1990, p. 340-342.

Research output: Contribution to journalArticle

Limonta, Monica ; Biondi, Andrea ; Giudici, Giovanni ; Specchia, Giorgina ; Catapano, Carlo ; Masera, Giuseppe ; Barbui, Tiziano ; D'Incalci, Maurizio. / Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells. In: Cancer Chemotherapy and Pharmacology. 1990 ; Vol. 26, No. 5. pp. 340-342.
@article{340d7e4d00eb43fb95cec926e1e60cfc,
title = "Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells",
abstract = "4-Demethoxydaunorubicin (4-DMDR) and its major metabolite 4-demethoxy-13-hydroxydaunorubicin (4-DMDRol) were investigated for their cytotoxicity and mode of action against human leukemic cells. The drug and its metabolite appeared to be equally potent as both inhibitors of cell proliferation and inducers of DNA double-strand breaks in the OCI AML-3 cell line and cells derived directly from patients with acute myeloid leukemia (AML). This suggests that 4-DMDRol plays an important role in the antileukemic activity of 4-DMDR.",
author = "Monica Limonta and Andrea Biondi and Giovanni Giudici and Giorgina Specchia and Carlo Catapano and Giuseppe Masera and Tiziano Barbui and Maurizio D'Incalci",
year = "1990",
month = "9",
doi = "10.1007/BF02897289",
language = "English",
volume = "26",
pages = "340--342",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells

AU - Limonta, Monica

AU - Biondi, Andrea

AU - Giudici, Giovanni

AU - Specchia, Giorgina

AU - Catapano, Carlo

AU - Masera, Giuseppe

AU - Barbui, Tiziano

AU - D'Incalci, Maurizio

PY - 1990/9

Y1 - 1990/9

N2 - 4-Demethoxydaunorubicin (4-DMDR) and its major metabolite 4-demethoxy-13-hydroxydaunorubicin (4-DMDRol) were investigated for their cytotoxicity and mode of action against human leukemic cells. The drug and its metabolite appeared to be equally potent as both inhibitors of cell proliferation and inducers of DNA double-strand breaks in the OCI AML-3 cell line and cells derived directly from patients with acute myeloid leukemia (AML). This suggests that 4-DMDRol plays an important role in the antileukemic activity of 4-DMDR.

AB - 4-Demethoxydaunorubicin (4-DMDR) and its major metabolite 4-demethoxy-13-hydroxydaunorubicin (4-DMDRol) were investigated for their cytotoxicity and mode of action against human leukemic cells. The drug and its metabolite appeared to be equally potent as both inhibitors of cell proliferation and inducers of DNA double-strand breaks in the OCI AML-3 cell line and cells derived directly from patients with acute myeloid leukemia (AML). This suggests that 4-DMDRol plays an important role in the antileukemic activity of 4-DMDR.

UR - http://www.scopus.com/inward/record.url?scp=0025042556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025042556&partnerID=8YFLogxK

U2 - 10.1007/BF02897289

DO - 10.1007/BF02897289

M3 - Article

C2 - 2208574

AN - SCOPUS:0025042556

VL - 26

SP - 340

EP - 342

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 5

ER -